GSK plc Announces Share Buyback Transaction

GSK plc has announced the purchase of 180,000 of its ordinary shares at a volume-weighted average price of 1,756.23p per share on 30 October 2025. This transaction is part of the company's existing buyback program, which has seen the purchase of 7,128,500 ordinary shares since 30 September 2025. Following this purchase, GSK will hold 254,593,344 ordinary shares in treasury and have 4,060,827,442 ordinary shares in issue, excluding treasury shares. The total number of voting rights in the company is 4,060,827,442, with 6.27% of voting rights attributable to the ordinary shares held in treasury.